Search results
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Novavax (NVAX) Q3 Earnings Miss, Lowers '22 Sales Outlook
Zacks via Yahoo Finance· 1 year agoNovavax, Inc. NVAX incurred a loss of $2.15 per share for third-quarter 2022, which missed the Zacks...
Novavax (NVAX) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoWe expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19...
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
Zacks via Yahoo Finance· 2 years agoCurrently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, Novavax (NVAX) closed at $20.17, marking a -1.61% move from the...
Let the Market’s Shakeout Finish Before Buying Novavax Stock
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) stock traders may be tempted to buy the dip after a share-price crash. Yet,...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation
Zacks via Yahoo Finance· 2 years agoThe European Medicines Agency's CHMP recommends expanded conditional marketing authorization for...
Novavax (NVAX) Q1 Earnings and Revenues Lag Estimates
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) delivered earnings and revenue surprises of -23.12% and 19.83%, respectively, for the...